Theorem Clinical Research

Global News

Amgen outlines strategy, will cut up to 4,000 jobs

Wednesday, October 29, 2014 01:28 PM

Amgen has outlined the company's strategy, growth objectives and capital allocation plans, and provided financial guidance for 2015. In addition to the approximately 2,900 positions already set to be eliminated by the end of 2015, an additional 600 to 1,100 jobs will be cut.

More... »


Qiagen, Astellas Pharma ink agreement to develop companion diagnostics

Wednesday, October 29, 2014 01:27 PM

Qiagen, a Netherlands-based provider of sample and assay technologies, has announced a master collaboration agreement with Astellas Pharma, an R&D-driven global pharmaceutical company headquartered in Japan, to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases.

More... »


TFS, SCIderm partner for global dermatology trials

Wednesday, October 29, 2014 01:26 PM

TFS International (TFS) and SCIderm have entered into a strategic partnership agreement to combine resources and scientific expertise within dermatology development.

More... »

ACRO to establish CRO forum to interact with TransCelerate Biopharma

Wednesday, October 29, 2014 01:25 PM

The Association of Clinical Research Organizations (ACRO), based in Wash. D.C., plans to constitute a CRO Forum to provide a formal mechanism for the CRO industry to furnish input into the work of TransCelerate BioPharma.

More... »

ClinGen launches patient portal GenomeConnect

Wednesday, October 29, 2014 01:20 PM

The Clinical Genome Resource (ClinGen), a NIH-funded resource dedicated to analyzing data from thousands of clinical genetics tests each year, has launched a new patient portal, GenomeConnect.

More... »

Johnson & Johnson Innovation, University of Toronto collaborate

Wednesday, October 29, 2014 01:18 PM

Janssen has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto's Center for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer's disease.

More... »

Synageva BioPharma reports positive results from LAL Deficiency study

Monday, October 27, 2014 01:46 PM

Synageva BioPharma, a biopharmaceutical company developing therapeutic products for rare disorders, has announced results of sebelipase alfa for LAL Deficiency in two different trials.

More... »

ERT named innovation award recipient by Philadelphia Business Journal

Monday, October 27, 2014 01:32 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has been honored as a 2014 Innovation Award Recipient by the Philadelphia Business Journal. The awards program recognizes the region’s leading companies for their innovations in the fields of healthcare and life sciences.

More... »

Cancer Innovation forum calls for improving cancer research ecosystem

Monday, October 27, 2014 12:58 PM

Accelerating the delivery of promising new cancer treatments depends on one critical requirement—ensuring patients are actively involved in the cancer research and drug development process from beginning to end.

More... »

Report: 10 men for every woman present in biotech boardrooms

Monday, October 27, 2014 12:57 PM

The biotechnology sector is considerably under represented by female executives and board directors, according to a new report by Liftstream, a U.K.-based company providing executive recruitment services to the biotechnology sector. The gender diversity report, Diversifying the Outlook—The X&Y of Biotechnology Leadership, is a detailed analysis of women leaders in European and U.S. biotech companies.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 27

NIH’s I-Corps boot camp aims to transform researchers into better businesspeople before they launch products

Covance, Frenova form partnership to share patient databases, find effective treatments for renal disease

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs